Skip to content

Author

Saurabh Dahiya

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Clonal hematopoiesis and cytopenias following CAR19 therapy

CD19-directed chimeric antigen receptor T cell therapy (CAR19) improves survival in relapsed/refractory large B cell lymphoma compared with immunochemotherapy with intent for autologous hematopoietic cell transplantation (autoHCT). However, major toxicities include prolonged cytopenias, infection and secondary hematolo...

M. Hamilton, Nick Phillips, T. Noordenbos et al. · 0 citations
Review Open access Jul 2026

Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas

The mechanisms underlying primary and secondary refractoriness to conventional single-targeting CAR-T therapies for B cell lymphomas are discussed and the ongoing challenges with existing CAR constructs are explored.

Toshali Pandey, D. Samat, Saurabh Dahiya et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.